Every summer since 2010, ten undergraduate students from diverse backgrounds get the opportunity to explore any curiosities they might have about careers in medicine at Memorial Sloan Kettering Cancer Center.
Four NCI-designated cancer centers—Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins—have joined together and secured funding from AWS, Deloitte, Microsoft, and NVIDIA, to create the Cancer AI Alliance.Â
A meta-analysis of 25 studies—totaling over 5,000 participants—focused on a question that has been troubling patients, physicians, and regulators: Does treatment with CAR T-cell therapy contribute to the development of secondary cancers?
Vittoria Bocchi, Julia Brunner, Melissa Yao, Tzippora Chwat-Edelstein named 2024 Kravis WiSE fellows
From left to right: Vittoria Bocchi, Melissa Yao, Julia Brunner, Tzippora Chwat-EdelsteinVittoria Bocchi, Julia Brunner, Melissa Yao, and Tzippora Chwat-Edelstein, four Sloan Kettering Institute researchers, were named 2024 Marie-Josée Kravis Women in Science Endeavor, or Kravis WiSE, fellowship grant recipients.
Memorial Sloan Kettering Cancer Center received a $400 million gift from Kenneth C. Griffin, Citadel founder and CEO, and David Geffen, founder of the David Geffen Foundation.Â
Mark Agnel Frederick DawsonCigall KadochMichelle MonjeMemorial Sloan Kettering Cancer Center has named three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.Â
Craig D. Blinderman was named chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center.Â
Michel SadelainCarl JuneMichel Sadelain, of Memorial Sloan Kettering Cancer Center, and Carl June, of University of Pennsylvania, are two of the recipients of the 2024 Breakthrough Prize in Life Sciences for the development of chimeric antigen receptor T-cell immunotherapy.
Irwin H. Krakoff, former director of the University of Vermont Cancer Center who has also served in key jobs at Memorial Sloan-Kettering Cancer Center and MD Anderson Cancer Center, died on Aug. 9 in Savannah, GA.
Results from a phase I trial at Memorial Sloan Kettering Cancer Center suggest that treatment with mRNA vaccines (autogene cevumeran) cause an effective and lasting immune response in some patients with pancreatic cancer.Â
